IMG 004
Alternative Names: HMPL 727; IMG-004Latest Information Update: 03 Jul 2024
At a glance
- Originator HUTCHMED
- Developer Inmagene
- Class Small molecules
- Mechanism of Action Agammaglobulinaemia tyrosine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase I Immunological disorders; Multiple sclerosis